Current Treatments for L4/5 Degenerative Spondylolisthesis

WEBINAR

Current Treatments for L4/5 Degenerative Spondylolisthesis

Faculty: Sheeraz Qureshi, Todd Albert, Michael Wang, Wellington Hsu

Notification icon This webinar took place on 
http://www.vumedi.com/webinar/current-treatments-for-l45-degenerative-spondylolisthesis/

Program

Sheeraz Qureshi

Mount Sinai Hospital, New York, NY.

Introduction to Degenerative Spondylolisthesis & Case Presentation

Todd Albert

Hospital for Special Surgery, New York, NY.

Defending Open Posterior Decompression and Fusion

Michael Wang

University of Miami School of Medicine, Miami, FL.

Defending the Lateral Approach

Wellington Hsu

Northwestern University Feinberg School of Medicine, Chicago, IL.

Defending MIS TLIF

Faculty:

  • Sheeraz Qureshi

    Mount Sinai Hospital, New York, NY.

  • Todd Albert

    Weill Cornell Medical College, New York, NY.

  • Michael W

    University of Miami School of Medicine, Miami, FL.

  • Wellington Hsu

    Northwestern University Feinberg School of Medicine, Chicago, IL.

Release: 05/11/2015

Expiration: 05/18/2015

Location: Online

Requirements for successful completion: In order to receive credit, participants must view all audio-visual presentations and complete both the pre-test, post-test and evaluation form. Participants must score 100% on the activity post-test in order to receive credit. There are no pre-requisites for this activity. Course attendance verification forms are provided upon successful completion of the post-test and evaluation form. No partial credit will be given.

Target Audience: Physicians, residents and trainees, fellows, nurses, surgical techs, physical therapists, and other members of the allied health community whose scope of practice encompasses Orthopaedics.

Course Description: In this live webinar, expert Spine, Oncology, Healthcare Policy, Practice Management, Foot & Ankle, Adult Reconstruction, Sports Medicine, Hand & Wrist, Trauma, Pediatric, Shoulder/Elbow will present optimal operable techniques and treatment options to address Current Treatments for L4/5 Degenerative Spondylolisthesis . The webinar features time for interactive audience discussion and surgical case based scenarios.

Learning Objectives: Upon completion of this activity, participants should be better able to discuss:

  1. Discuss what degenerative spondylolisthesis is and how it can be treated
  2. Discuss open posterior decompression and fusion as treatment for degenerative spondylolisthesis
  3. Discuss the use of the lateral approach as treatment for degenerative spondylolisthesis
  4. Discuss the use of the MIS TLIF approach as treatment for degenerative spondylolisthesis

Credits: This lecture qualifies for 2 CME credit hours.

Cost: $0.0

Accreditation Statement: This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the The International Institute for Continuing Medical Education, Inc and VuMedi. The International Institute for Continuing Medical Education, Inc is accredited by the Accreditation Council for Continuing Medical Education to provide medical education to physicians.

Designation Statement: The International Institute for Continuing Medical Education, Inc designates this live activity for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty Disclosures: Faculty Disclosures/Conflict of Interest Policy\nIn accordance with ACCME requirements, The International Institute for Continuing Medical Education, Inc, has a conflict of interest policy that requires faculty to disclose relevant financial relationships related to the content of their presentations/materials. Any potential conflicts are resolved so that presentations are evidence-based and scientifically balanced. The relationships were reviewed by The International Institute for Continuing Medical Education, Inc. and conflicts of interest were resolved prior to the activity.

Dr. Sheeraz Qureshi discloses the following relevant financial relationships with a commercial interest: AAOS: Board or committee member, Cervical Spine Research Society: Board or committee member, Clinical Orthopaedics and Related Research: Editorial or governing board, Contemporary Spine Surgery: Editorial or governing board, Global Spine Journal: Editorial or governing board, Globus Medical: Paid presenter or speaker, Medtronic: Paid consultant, Medtronic Sofamor Danek: Paid presenter or speaker, Musculoskeletal Transplant Foundation: Board or committee member, NASS: Board or committee member, Orthofix, Inc.: Paid consultant, Spine (reviewer): Editorial or governing board, Spine Journal (reviewer): Editorial or governing board, Stryker: Paid consultant; Paid presenter or speaker, Zimmer: IP royalties; Paid consultant

Dr. Todd Albert discloses the following relevant financial relationships with a commercial interest: AAOS: Board or committee member, American Orthopaedic Association: Board or committee member, ASIP: Stock or stock Options, Biomet: IP royalties, Biometrix: Stock or stock Options, Breakaway Imaging: Stock or stock Options, Crosstree: Stock or stock Options, DePuy, A Johnson & Johnson Company: IP royalties; Paid consultant, FacetLink: Paid consultant; Stock or stock Options, Gentis: Stock or stock Options, In ViVo Therapeutics: Stock or stock Options, Invuity: Stock or stock Options, Jay Pee: Publishing royalties, financial or material support, Journal of Bone and Joint Surgery - American: Editorial or governing board, Paradigm Spine: Stock or stock Options, Pioneer: Stock or stock Options, PMIG: Stock or stock Options, Saunders/Mosby-Elsevier: Publishing royalties, financial or material support, Scoliosis Research Society: Board or committee member, Spine: Editorial or governing board, Spine Deformity Journal: Editorial or governing board, Spinicity: Stock or stock Options, Thieme: Publishing royalties, financial or material support, United Healthcare: Other financial or material support, Vertech: Stock or stock Options

Dr. Michael Wang discloses the following relevant financial relationships with a commercial interest: DePuy, A Johnson & Johnson Company: IP royalties; Paid consultant; Paid presenter or speaker, Quality Medical Publishing: Publishing royalties, financial or material support, Spinicity: Stock or stock Options, Springer: Editorial or governing board

Dr. Wellington Hsu discloses the following relevant financial relationships with a commercial interest: AAOS: Board or committee member, AONA: Paid consultant; Paid presenter or speaker, Bacterin: Paid consultant, Bioventus: Paid consultant, CeramTec: Paid consultant, Cervical Spine Research Society: Board or committee member, Globus: Paid consultant, Graftys: Paid consultant, Journal of Spinal Disorders and Techniques: Editorial or governing board, Lifenet: Paid consultant, Lumbar Spine Research Society: Board or committee member, Medtronic: Paid consultant; Research support, North American Spine Society: Board or committee member, Pioneer: Paid consultant, Relievant: Paid consultant, Stryker Spine: Paid consultant, Synthes: Paid consultant

Faculty Disclosures of Unlabeled Use: The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use. No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.

Dr. Sheeraz Qureshi does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Dr. Todd Albert does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Dr. Michael Wang does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Dr. Wellington Hsu does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Commercial Support: No commercial support was received for this activity.

Software Requirements: VuMedi Webinars supports the following web browsers (with enabled JavaScript™): Internet Explorer® versions 6.0, 7.0, 8.0, Mozilla Firefox versions 1.0, 2.0, 3.0, and Safari for Mac. Certain educational activities may require additional software to view multimedia, presentation or printable versions of their content. That software may be: Adobe Acrobat®, Adobe® Flash Player, Microsoft® Office PowerPoint, and Microsoft® Office Word.These activities will be marked as such and will provide links to the required software.

Copyright: Any and/or all materials are for the exclusive use of the faculty and participants of the live activity. Any copying, duplicating or reproducing of any and/or all materials by electronic, mechanical or other means for any purpose other than this enduring activity is strictly prohibited without prior written consent of the author of those materials.

Policy on Privacy and Confidentiality: For more information regarding VuMedi's Policy on Privacy and Confidentiality, please visit http://www.vumedi.com/pages/privacy/

To Contact our Accredited Provider: 6438 US Hwy 11
Springville, AL 35146
Phone: (205) 467-0290
Fax: (205) 467-0195
email: iicmemail@gmail.com

For questions regarding this activity, please contact VuMedi: cme@vumedi.com


7 Comments
Login to view comments. Click here to Login